Geneos Wealth Management’s Revvity RVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-44
Closed -$3.88K 2542
2025
Q3
$3.88K Sell
44
-27
-38% -$2.45K ﹤0.01% 2202
2025
Q2
$6.87K Hold
71
﹤0.01% 2464
2025
Q1
$7.51K Buy
71
+26
+58% +$3K ﹤0.01% 2378
2024
Q4
$5.02K Hold
45
﹤0.01% 2333
2024
Q3
$5.75K Buy
+45
New +$5.29K ﹤0.01% 2030
2023
Q1
Sell
-110
Closed -$15.4K 2090
2022
Q4
$15.4K Buy
+110
New +$14.8K ﹤0.01% 1413
2022
Q2
Sell
-4
Closed 2759
2022
Q1
$0 Buy
+4
New +$711 ﹤0.01% 2944
2021
Q2
Sell
-98
Closed -$12K 3069
2021
Q1
$12K Buy
+98
New +$13.6K ﹤0.01% 2303

Other funds holding RVTY

Geneos Wealth Management's RVTY Position: Q4 2025 in Review

Geneos Wealth Management sold out of Revvity (RVTY) in Q4 2025, closing a stake of 44 shares — an estimated $3.88K sold.

Geneos Wealth Management first reported a position in RVTY in Q1 2021 and held it in 8 quarters. The position peaked at $15.4K in Q4 2022. 511 funds tracked by Wall St. Rank hold RVTY as of Q4 2025.

  • Geneos Wealth Management reported no remaining Revvity position as of Q4 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 44 Revvity shares in Q4 2025, an estimated $3.88K.
  • Geneos Wealth Management first reported a position in Revvity in Q1 2021 and held it in 8 quarters.
  • Geneos Wealth Management's Revvity position peaked at $15.4K in Q4 2022.
  • 511 funds tracked by Wall St. Rank held Revvity as of Q4 2025.

Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.